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Summary
Supercharged proteins can deliver functional macromolecules into the cytoplasm of mammalian
cells with potencies that exceed those of cationic peptides. The structural features of supercharged
proteins that determine their delivery effectiveness and the intracellular fate of supercharged
proteins once they enter cells have not yet been studied. Using a large set of supercharged GFP
(scGFP) variants, we found that the level of cellular uptake is sigmoidally related to net charge,
and that scGFPs enter cells through multiple pathways including clathrin-dependent endocytosis
and macropinocytosis. Supercharged proteins activate Rho and ERK1/2, and also alter the
endocytic transport of transferrin and EGF. Finally, we discovered that the intracellular trafficking
of endosomes containing scGFPs is altered in a manner that correlates with protein delivery
potency. Collectively, our findings establish basic structure-activity relationships of supercharged
proteins and implicate the modulation of endosomal trafficking as a determinant of cell-
penetration and macromolecule-delivery efficiency.
Introduction
The vast majority of nucleic acids and proteins encoded by the human genome are
intracellular. Molecular strategies to perturb the function of most biological targets for
research or therapeutic purposes therefore require agents that can enter cells. While
membrane-permeable small molecules have dominated therapeutics over the past several
decades, the use of macromolecules to address biomedical targets has more recently become
a focus of intense research (Leader et al., 2008), resulting in a number of macromolecular
human drugs (Overington et al., 2006). Macromolecules can offer significant advantages
over traditional small molecule-based therapeutics. Macromolecules possess sizes and
folding energies that are ideal for catalyzing chemical reactions, potently and selectively
binding to extended target surface areas, and encoding gene products. These key features,
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juxtaposed with the inability of virtually all macromolecules to spontaneously enter cells,
create an urgent need to develop effective and general methods for the delivery of functional
proteins and nucleic acids into mammalian cells (Schaffert and Wagner, 2008; Gu et al.,
2011).
While a host of protein delivery methods have been developed over the past decade— most
notably those based on cationic cell-penetrating peptides (CPPs) (Wadia and Dowdy, 2003;
Heitz et al., 2009), but also including antibodies (Song et al., 2005), receptor ligands (Rizk
et al., 2009), nanoparticles (Hasadsri et al., 2009), and virus-like particles (Voelkel et al.,
2010) — these approaches have not achieved widespread use, and modestly successful
protein delivery has historically required high doses of purified protein. We recently
developed a platform for macromolecule delivery in vitro and in vivo based on supercharged
proteins (SCPs) (Cronican et al., 2011; Cronican et al., 2010: McNaughton et al., 2009).
SCPs possess extremely high positive theoretical net charge at their surfaces and candidate
SCPs can be generated computationally from native, non-supercharged proteins (Lawrence
et al., 2007). Proteins can be mutated into SCPs without necessarily abolishing the protein's
native structural or functional properties (Lawrence et al., 2007). Recently, we identified a
class of naturally occurring supercharged human proteins with theoretical net
charge:molecular weight ratios similar to those of engineered SCPs (Cronican et al., 2011).
These naturally occurring human SCPs exhibit similar potent cellular uptake and
macromolecule-delivery properties as engineered SCPs. When compared to the most
commonly used cell-penetrating peptides (CPPs) and commercial nucleic acid delivery
reagents, SCPs can result in more effective protein and nucleic acid delivery across a range
of cell and tissue types in vitro and in vivo (Cronican et al., 2010; McNaughton et al., 2009;
Cronican et al., 2011).
The molecular mechanisms by which SCPs enter and are trafficked in cells are largely
unknown. Previous studies suggest that cell entry of SCPs shares some mechanistic features
with that of other cationic delivery reagents (McNaughton et al., 2009), such as binding to
sulfated proteoglycans to mediate initial cellular association, followed by endocytosis and
some degree of endosomal escape to the cytosol. However, SCPs can be more efficient at
achieving both cell entry and functional macromolecule delivery to the cytosol than CPPs
(Cronican et al., 2010; McNaughton et al., 2009). It is not understood whether the high
delivery potency of SCPs compared with CPPs results solely from the higher theoretical net
charges attained by SCPs, or from the globular, structured nature of SCPs compared with
much shorter and less structured peptide tags. Observations that support the latter hypothesis
include: (i) increasing the theoretical net charge of CPPs beyond approximately +15
typically does not increase, and eventually decreases, their cell penetration potency
(Mitchell et al., 2000); (ii) substitution of arginines on the surfaces of small proteins has
been shown to endow these proteins with cell-penetrating abilities (Daniels and Schepartz,
2007) beyond those of similarly charged cationic peptides; (iii) the cell-penetration
capabilities of oligoarginine peptides have been enhanced by the introduction of disulfide
bonds that presumably stabilize the three-dimensional structure of the cationic peptide (Lee
et al., 2011); (iv) introducing spacer sequences between cationic residues throughout an
oligoarginine peptide has also been shown to increase the effectiveness of cellular uptake
(Rothbard et al., 2002); (v) the distribution of cationic residues on the surface of proteins,
and not merely charge magnitude, has been shown to alter the effectiveness of certain cell-
penetrating proteins (Turcotte et al., 2009). Consistent with these findings, we have
observed that SCPs exhibit more potent cell penetration and nucleic acid delivery abilities
than synthetic peptides of similar or even greater positive theoretical net charge
(McNaughton et al., 2009).
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In this work we investigate in detail the role of theoretical net charge and charge distribution
on the cellular uptake and delivery properties of SCPs using supercharged GFP (scGFP) as a
model. We examined the extent to which SCPs and CPPs alter endocytic processes using a
wide range of biochemical assays and high-throughput confocal microscopy. We find that
cellular uptake and delivery potencies are strongly charge-dependent, and that supercharged
proteins outperform unstructured peptides of similar charge. We further find that delivery
potency correlates with the activation of specific cellular signaling markers, altered
endocytosis, and subcellular trafficking. These findings provide mechanistic insights into the
unusual ability of supercharged proteins to enter cells and deliver macromolecules, and
inform the future development and application of these agents.
Results
Effect of charge magnitude on cellular uptake
Previously we observed that the CPPs Tat, Arg10, and penetratin delivered protein into cells
with up to 100-fold lower potencies than that of +36 GFP (Cronican et al., 2010), and that
protein and nucleic acid delivery efficiencies mediated by three supercharged GFP variants
(+15, +25, and +36 GFP) correlated with their theoretical net charge (McNaughton et al.,
2009). These observations prompted us to characterize in detail (i) the relationship between
net theoretical charge and cellular uptake potency, and (ii) the effect of charge distribution,
either across the surface of a protein or within an unstructured peptide tag, on cellular uptake
and delivery potency.
To elucidate these relationships, we generated a collection of 28 scGFP variants with a wide
range of theoretical net charges as well as different patterns of charge distribution (Figure
S1). Genes encoding the variants were constructed by combining DNA fragments derived
from the coding sequences of previously developed GFPs: stGFP (starting GFP, a non-
supercharged variant), +15 GFP, +25 GFP, +36 GFP, and +48 GFP (Lawrence et al., 2007).
Each resulting scGFP variant was expressed and purified from E. coli cells. The absorbance
and fluorescence emission spectra of all 28 scGFPs were very similar (Supplemental
Information Figure S2), enabling us to use fluorescence to directly compare the cellular
uptake of these proteins.
To determine the relationship of charge to cell uptake, each scGFP variant was incubated
with HeLa cells for 4 hours across a range of concentrations. Following incubation, cells
were washed using conditions previously shown to remove excess non-internalized protein
(Cronican et al., 2010; McNaughton et al., 2009; Cronican et al., 2011), trypsinized, and
assayed for protein uptake by flow cytometry. For comparison, Tat-stGFP and a GFP
engineered by Raines and coworkers to contain an arginine patch (Fuchs and Raines, 2007)
were also incubated with HeLa cells and processed in an identical manner. The degree of
cellular uptake was measured as the median cellular fluorescence of the population of cells.
The relationship of theoretical net charge to cellular uptake was found to be strongly
sigmoidal, and consistent across doses ranging from 20 nM to 2 μM (Figure S3). Low-
potency uptake, comparable to that of Tat peptide, was observed among proteins with net
theoretical charge < ~+20. In contrast, a high-potency regime exhibiting 100-fold higher
cellular uptake potency was observed for highly charged proteins (Figure 1A). For GFP, the
inflection point between the lowand high-potency regimes occurs at a theoretical net charge
of approximately +22 (Figure 1A, green points), well above the net charge of CPPs. As this
net charge versus cellular uptake relationship predicts, Tat-stGFP (+1 theoretical net charge)
exhibited potency comparable to that of other modestly charged, low-potency charged GFP
variants, including the Arg-grafted GFP (Fuchs and Raines, 2007) (Figure 1A). The striking
change in cell penetration effectiveness from low- to high-potency variants suggests that
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these variants may enter cells through the involvement of different cellular interactions or
through distinct uptake pathways.
Effect of charge distribution on cellular uptake
To examine the effect of SCP charge distribution on cell penetration, we generated a series
of scGFPs that alter charge distribution without varying theoretical net charge, which was
maintained at approximately +25 and +36. The variants within this series were constructed
from segments of +48 GFP together with segments of +15 GFP and +25 GFP and therefore
contained a more uneven cationic charge distribution than canonical +25 or +36 GFPs, with
basic residues concentrated into more limited regions of the protein surface. We observed
significantly different levels of cellular uptake potencies among scGFPs with similar or
identical theoretical net charges but different charge distribution patterns (Figure 1B, red
points). These results confirm that the distribution of cationic groups on the surface of a
supercharged protein, and not simply the theoretical net charge of the protein, contributes to
its cellular uptake properties.
To account for the possibility that interaction between densely substituted cationic residues
influences their protonation state and the net charge of scGFPs, we performed cation
exchange and found that all proteins eluted in a manner consistent with their relative
theoretical net charge rather than with their observed level of cellular uptake (Supplemental
Text and Figure S4). Additionally, we tested whether the voltage of the scGFPs was affected
by the distribution of charged residues, and found that some of the uptake deficiencies of
weakly performing scGFPs can be accounted for using a model that describes the electric
field of a protein in solution (Supplemental Text and Figure S5)
Taken together, these findings are consistent with a model in which at least one cellular
uptake potency-determining event, such as proteoglycan binding or receptor crosslinking
(Nakase et al., 2006), is dependent on the arrangement of cationic groups on the surface of a
supercharged protein, and not simply on its net charge.
Charge dependence of scGFP-mediated protein delivery
The cell-penetration properties of macromolecule delivery agents can depend strongly on the
associated cargo (Cronican et al., 2010). To determine whether the observed charge-uptake
relationship for scGFPs is sustained for scGFP-mediated delivery of fused proteins, a subset
of scGFPs were fused to either mCherry or to Cre recombinase (Shaner et al., 2004; Guo et
al., 1997). GFPs with theoretical net charges of +9, +15, +24, +25 (three variants designated
+25, +25A, and +25B), +35, +36, +37, and +48 were chosen as fusion partners to cover a
range of theoretical net charges, and to include some variants with altered charge
distributions that performed below the level predicted by their theoretical net charge alone.
For comparison, the CPPs Tat, Arg10, and penetratin were also prepared as fusions with
mCherry and Cre recombinase.
HeLa cells were incubated with mCherry fusions for 4 hours at 50 nM to 2 μM, washed, and
analyzed by flow cytometry using mCherry fluorescence as a measure of protein delivery.
The mCherry fusions retained the same general trend of charge-dependent cellular uptake
observed for scGFPs alone, with low-potency delivery transitioning to high-potency delivery
(up to 50-fold more potent) for variants with > +15 theoretical net charge (Figure 1C). We
also observed lower cell penetration potency of the same high-charge variants that
underperformed in the cellular uptake study described above (+25A, +25B, +35, +37, and
+48 GFPs) (Figure 1C). Fusions with CPPs performed as previously observed, with low
overall mCherry delivery potency comparable to that of the +9 GFP-mCherry fusion, except
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for penetratin-mCherry, which resulted in moderate levels of delivery at the highest
concentrations tested (1 to 2 μM).
Next we used scGFP-Cre recombinase fusions to assay the functional delivery of protein
enzymes to the cytosol. BSR.LNL.tdTomato cells (Cronican et al., 2010) were used to report
Cre-dependent recombination. Since scGFP-Cre fusions have little or no recombinase
activity until the scGFP moiety is cleaved from the recombinase moiety (Cronican et al.,
2010), we first digested the purified proteins with cathepsin B to cleave the linker between
scGFP and Cre and assayed the resulting proteins in vitro as previously described (Cronican
et al., 2010). All cathepsin B-digested scGFP-Cre fusions exhibited recombinase activities
comparable to that of wild-type Cre (Supplemental Information Figure S6). In addition to
being cleaved from scGFP, delivered Cre recombinase must also tetramerize, escape
endosomes, translocate to the nucleus, and recombine the reporter gene cassette to trigger
tdTomato reporter gene expression. Cells were incubated with each of the scGFP-Cre
fusions across a range of concentrations for 4 hours, washed to remove non-internalized
proteins as before, then incubated further in protein-free media for 48 hours.
The percent of recombinant cells resulting from each treatment was revealed by flow
cytometry. The Tat, Arg10, and penetratin Cre fusions exhibited functional recombinase
delivery efficiencies in the low-potency regime, consistent with previously reported results
(Cronican et al., 2011; Cronican et al., 2010). Functional Cre delivery by scGFPs, in contrast
to mCherry delivery, was strictly charge-dependent, with higher charged scGFPs producing
more recombinant cells, and like-charged variants clustering together (Figure 1D).
Interestingly, variants that were observed to be internalized with significantly lower
efficiency than +36 GFP, such as +37 GFP and +48 GFP, when fused to Cre resulted in
comparable or even greater recombinant cells than +36 GFP, respectively. The differences
between the cellular uptake potencies of these scGFPs (Figure 1C) and their strictly charge-
dependent ability to deliver functional Cre (Figure 1D) suggests that protein-intrinsic factors
downstream of internalization, such as cleavage of the fusion or endosomal escape
efficiency, are potency-limiting in the latter case.
To test these possibilities, Cre delivery was repeated in the presence of chloroquine, a small
molecule that enhances endosomal escape and increases functional delivery potency of
supercharged proteins (Cronican et al., 2010). Importantly, the profile of charge- and dose-
dependent Cre recombination (Figure 1D) is significantly shifted towards greater functional
delivery in the presence of 100 mM chloroquine (Figure 1E), and closely reflects the pattern
of total fusion protein uptake (Figure 1C). To probe potential differences in cleavage
efficiency of Cre fused to different supercharged proteins, we subjected +15 GFP-Cre and
+36 GFP-Cre to in vitro and cell-based cleavage assays. Both proteins were found to be
equally cleavable (Figure S7A and B), suggesting that proteolytic cleavage efficiency is not
a determinant of the different observed functional delivery abilities. We also assayed the
effect of blocking cleavage by co-incubation of BSR reporter cells with +36 GFP-Cre and a
broad cathepsin inhibitor, Z-Phe-Gly-NHO-Bz (Demuth et al., 1996). At low doses (0.1–0.5
μM) there is a clear depression of delivery (Figure S8), presumably due to a failure to
liberate Cre from +36 GFP. At high doses (2–100 μM), the efficiency of Cre delivery is
dramatically improved (Figure S8), possibly due to continued inhibition of endosomal
proteases that would otherwise degrade Cre.
Taken together, these results suggest that functional protein delivery by scGFPs is charge-
dependent and protease-dependent, and that this dependence is at least partially the result of
post-internalization processes. Processes that are likely to influence the intracellular survival
and functional delivery of a protein, such as endosomal trafficking, maturation, or escape,
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may therefore be affected by the presence of highly cationic molecules within endosomes, a
hypothesis explored in the experiments below.
Comparing delivery potencies of scGFPs and similarly charged cationic peptides
The above studies implicate theoretical net charge as a strong determinant of cell penetration
and protein delivery potency. Next we sought to determine the effect of protein structure on
cellular uptake and protein delivery potency by measuring the delivery efficiency of proteins
fused to Arg- and Lys-rich peptides with Lys/Arg content comparable to that of scGFPs.
Because genes encoding simple fusions of mCherry or Cre to polycationic Arg or Lys
peptides longer than 10 amino acids did not express efficiently in E. coli, we used an
enzyme-mediated protein ligation strategy to generate these proteins. The synthetic peptides
(KKR)3R, (KKR)6KR, and (KKR)9KRR were efficiently conjugated to mCherry and Cre
using a highly active mutant sortase enzyme recently evolved in our laboratory
(Supplemental Information Experimental Procedures) (Chen et al., 2011). The resulting
poly-Lys/Arg-fused mCherry and Cre proteins were incubated with reporter cell lines as
described above. For comparison, cells were also treated with mCherry and Cre fused to +9,
+15, +25, or +36 GFP, which collectively span the range of theoretical net charges covered
by the poly-Lys/Arg-fused proteins. Cellular uptake and protein delivery potencies were
quantitated by flow cytometry as before.
For mCherry delivery, scGFP fusions consistently outperformed fusions with similarly
charged poly-Lys/Arg-conjugated mCherry (Figure 2A). This difference was especially
pronounced at lower concentrations. While at higher concentrations fusions with +20 and
+30 peptides approached the performance levels of fusions with +25 GFP, in most cases and
at most concentrations scGFPs resulted in more mCherry delivery than both similarly
charged and more highly charged cationic peptides (Figure 2B). These results indicate that
scGFP proteins result in distinctly more potent cellular uptake and mCherry delivery than
unstructured cationic peptides, even when the scGFP and the cationic peptides possess a
similar theoretical net charge.
The results for Cre recombinase delivery were generally consistent with the mCherry
delivery results; scGFP-Cre fusions typically outperformed cationic peptide-Cre fusions,
especially at lower doses, with the exception of the lower potency +9 and +15 GFPs (Figure
2C). Interestingly, the +20 and +30 poly-Lys/Arg peptides exhibited decreased Cre delivery
potency compared with +10 poly-Lys/Arg, which is approximately as effective as Arg10-Cre
(Figure 1D), despite the fact that all Cre conjugates and fusions were comparably active in
vitro following cathepsin B treatment (Supplemental Information Figure S7) (Cronican et
al., 2010). A possible explanation for the lower potency of the +20 and +30 poly-Lys/Arg
peptides is their potential cytotoxicity, as has been previously reported for certain cationic
peptides and other synthetic cationic polymers (Mitchell et al., 2000; Godbey et al., 1999).
This toxicity may not have manifested on the shorter timescale of the mCherry
internalization assays, while the Cre assay is necessarily a multi-day experiment.
Collectively, these results reveal a cellular uptake and protein-delivery potency advantage
from displaying positive charge on a structured protein surface, as is this case with scGFPs,
over simply appending the same number of cationic residues in a simple, presumably
unstructured peptide tag. This difference may be explained if the higher density of Arg and
Lys side chains in a short peptide prevents the complete protonation of every residue by
decreasing their pKa values to reduce unfavorable charge-charge repulsion, decreasing the
actual cationic net charges attainable by synthetic peptides compared with supercharged
proteins. Alternatively, spreading cationic residues over a much larger surface area may
engage cell-surface receptors or other proteins involved in endocytosis and/or escape from
endosomes more effectively than concentrating cationic charge in a small peptide tail. We
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tested the former possibility using the same cation-exchange-based approach that we used to
assess the actual charge magnitudes of scGFPs. Poly-Lys/Arg peptides eluted from the
cation exchange resin in a manner consistent with their theoretical net charge (Supplemental
Information Figure S4). These results support a model in which the potency differences
between cationic peptides and supercharged proteins arise from differences in their ability to
interact with cellular components rather than from differences in their actual versus
theoretical net charge.
Mechanisms of scGFP internalization
We previously reported that scGFP uptake is an energy-dependent process that requires
actin polymerization and the presence of cell-surface sulfated proteoglycans (McNaughton
et al., 2009). Given these findings, one possibility is that scGFP may be taken up via
macropinocytosis, similar to some CPPs (Wadia et al., 2004; Nakase et al., 2006). In light of
the observed cellular uptake and macromolecule delivery differences between scGFPs and
cationic CPPs, however, we hypothesized that significant mechanistic differences in their
cellular internalization may also exist. We therefore probed the uptake of scGFP in greater
detail.
We used a collection of known endocytic inhibitors to probe the role of different endocytic
pathways in the uptake of scGFP. HeLa cells were pre-treated with each inhibitor for 1 hour
prior to incubation with 500 nM +36 GFP and inhibitor for an additional hour (Figure 3A
and S9). Cells were washed as described above and scGFP uptake was measured by flow
cytometry. Amiloride prevents the activation of macropinocytosis (Dangoria et al., 1996)
that are implicated in the uptake of cationic CPPs, and inhibits Tat peptide delivery nearly
completely at 5 mM (Wadia et al., 2004). In contrast, 5 mM amiloride reduced uptake of
scGFP by only 48%. Likewise, cytochalasin D, an inhibitor of actin polymerization, blocked
uptake of scGFP by 45% at 10 μM,, but has been reported to block Tat peptide uptake by
>90% (Wadia et al., 2004). These findings suggest that, in contrast to most cationic CPPs,
scGFP uptake is not entirely dependent on macropinocytosis and actin-dependent processes.
Interestingly, 5 μg/mL chlorpromazine, which prevents the formation of clathrin-coated pits,
and 50 μM dynasore, which prevents the scission of clathrin-coated vesicles (Wang et al.,
1993; Macia et al., 2006), inhibited uptake of +36 GFP by 78% and 62%, respectively.
Finally, nystatin and filipin, two inhibitors of caveolin-dependent uptake which is involved
in the internalization of some viral delivery agents and non-viral protein-based agents
(Rothberg et al., 1992; Rothberg et al., 1990), resulted in no observable impact on scGFP
uptake at 50 nM of either inhibitor. These inhibitor studies collectively implicate a clathrin-
dependent endocytosis as a major mechanism for the uptake of scGFP, and suggest that
macropinocytosis plays a lesser role.
To test whether scGFPs modulate clathrin-dependent uptake, we incubated HeLa cells with
fluorophore-labeled transferrin, a known clathrin-dependent cargo, and Tat-mCherry,
penetratin-mCherry, (KKR)9KRR-mCherry, +15 GFP, or +36 GFP at concentrations from
0.1 to 2 μM (Figure 3B). Co-incubation with +36 GFP resulted in a marked dose-dependent
increase in intracellular transferrin. None of the other proteins tested had an appreciable
effect on transferrin uptake. Titration of transferrin (20 to 200 μg/mL) in the presence of 200
nM +36 GFP had little effect on +36 GFP uptake, indicating that +36 GFP does not use the
same receptor as transferrin but instead stimulates transferrin accumulation independently.
We also tested the +35 and +37 GFP, two proteins that are taken up by cells less efficiently
than +36 GFP (Figure 1B and 1C), to see if their lower potency could be explained by a
differential effect on the endocytic system but found no appreciable difference in
intracellular transferrin levels compared with +36 GFP (Supplemental Information Figure
S10A). The stimulation of transferrin accumulation by +36 GFP may implicate clathrin in
the uptake of scGFP and suggests that high-potency scGFPs potently alter endocytic
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processes that rely on this pathway. These results also represent a distinction between high-
potency scGFPs and other proteins and peptides tested.
Given the partial inhibition of +36 GFP uptake by the macropinocytosis inhibitor amiloride,
we tested the effect of epidermal growth factor (EGF), a known inducer of
macropinocytosis, on +36 GFP uptake. Across a range of concentrations (0.1 to 1 μg/mL),
EGF had no significant impact on +36 GFP uptake (Supplemental Information Figure
S10B). However, when the internalization of labeled EGF was studied as function of the
concentration of +36 GFP, +15 GFP, Tat-mCherry, penetratin-mCherry, and (KKR)9KRR-
mCherry (0.1 to 2 μM each), EGF uptake was inhibited by +15 GFP, +36 GFP, and
(KKR)9KRR-mCherry by up to 40% (Figure 3C). This observation indicates that high-
potency cell-penetrant proteins such as +36 GFP may either compete with EGF for
receptors, strongly induce ligand-independent internalization of EGF receptors through (a
known mechanism of EGFR regulation) (West et al., 1989; Goh et al., 2010), or alter EGFR
activation, internalization, or degradation through another mechanism. Finally, we examined
whether scGFPs damage the cellular membrane, thereby inducing endocytosis via
membrane repair pathways (Duchardt et al., 2007). Even at a high dose (10 μM), +36 GFP
does not induce appreciable membrane permeabilization (Figure S11).
Collectively, these mechanistic studies indicate that high-potency scGFPs enter cells through
uptake pathways that include clathrin-dependent endocytosis, which may be altered by
scGFPs, and macropinocytosis. Furthermore, scGFPs cause significant changes to the
transport of both recycling and degradative endocytic cargoes. Such changes correlate with
the potency of protein delivery.
Rho activation by scGFPs and poly-Lys/Arg peptides
The above observations suggest that scGFPs enter cells through specific endocytic routes.
Next we characterized the effects of scGFPs on key protein components in endocytosis
pathways. Charged peptides including Tat and Arg10 have been shown to induce the
activation of Rac GTPase (Nakase et al., 2006), an early step required for the induction of
macropinocytosis. Rho and Rac are GTPases involved in cytoskeletal reorganization and
endosomal trafficking (Lua and Low, 2005; Qualmann and Mellor, 2003). Rac is located
near the plasma membrane and initiates actin polymerization at the start of macropinosome
formation (West et al., 2000). Rho is downstream of multiple endocytic pathways, including
caveolin-dependent uptake, and clathrin-independent phagocytosis of particulate matter
(Ellis and Mellor, 2000). Rac, on the other hand, is associated with fluid-phase endocytosis
(West et al., 2000).
We assayed the activation of the GTP-bound form of Rho and Rac GTPases by scGFPs and
poly-Lys/Arg peptides using a colorimetric plate-based “GLISA” (Cytoskeleton, Inc.). The
initial binding events of scGFP and cationic peptides depend on association with sulfated
proteoglycans (McNaughton et al., 2009), and the binding and crosslinking of proteoglycans
is known to activate endocytosis (Wittrup et al., 2009; Dehio et al., 1998). We therefore
used CHO cells as well as mutant CHO pgsA− cells defective for xylosyltransferase (Esko et
al., 1985), which is responsible for sulfation of proteoglycans, as a control. Cells were
incubated for 5 minutes with proteins, harvested, and lysed. The resulting cell lysates were
applied to GLISA plates. Upon treatment with high-potency scGFPs and poly-Lys/Arg
peptides, Rho was activated roughly 2-fold compared with untreated controls (Figure 3D).
Low-charge variants resulted in significantly lower activation levels, consistent with the
observed sigmoidal charge-uptake relationship for scGFP and scGFP-mCherry fusions
(Figures 1A and 1C). Treatment of the CHO pgsA− cells resulted in low Rho activation
across all treatments, indicating that Rho activation is dependent on sulfated proteoglycans
(Figure 3D, dark bars). Importantly, the activation of Rho by scGFPs is consistent with our
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observation of a +36GFP-dependent intracellular transferrin accumulation (Figure 3B), as
Rho plays an important role in clathrin organization, cargo sorting, and endosome motility
(Ellis and Mellor, 2000).
We also assayed the activation of GTP-bound Rac by GLISA following treatment with
scGFPs or poly-Lys/Arg peptides, and observed no activation by scGFPs and weak
activation by poly-Lys/Arg peptides (Figure 3E), consistent with observations by others that
Rac activation increases following treatment with either Arg8 or Tat peptides (Nakase et al.,
2006). Rho and Rac are known to negatively regulate one another (Sander et al., 1999), and
significant Rho activation may depress Rac levels. Given the role of Rho in the activation
and maturation of different endocytic pathways (Ellis and Mellor, 2000; West et al., 2000),
the above results could provide a molecular explanation for the scGFP-mediated alteration
of transferrin and EGF endocytosis (Figure 3B and 3C).
ERK1 activation by scGFPs and poly-Lys/Arg peptides
In many cell lines, endocytosis is required for full activation of ERK1/2 following receptor
ligation (Pierce et al., 2000; Robertson et al., 2006; Ung et al., 2008). Therefore, changes in
ERK1/2 phosphorylation can reflect activation of plasma membrane signaling receptors by
scGFPs or changes in the endocytic transport of these receptors (Sorkin and von Zastrow,
2009).
We measured ERK1/2 phosphorylation by immunoblot analysis of cell lysates treated for 5
minutes with scGFP or poly-Lys/Arg variants to quantitate phospho-ERK1/2 levels. Upon
treatment with highly charged scGFPs, but not similarly charged poly-Lys/Arg peptides,
cellular ERK1/2 was phosphorylated by up to 8.4-fold over controls lacking treatment
(Figure 3F). More modestly charged (+9 or +15) scGFPs also induced ERK1/2
phosphorylation, although to a lower extent (Figure 3F). In all cases tested, ERK 1/2
phosporylation was also dependent on the presence of sulfated proteoglycans, as evidenced
by the lack of ERK1/2 phosphorylation in the CHO pgsA− cells (Figure 3F, dark bars). This
finding suggests that the activation of receptor signaling, and possibly receptor
internalization, is an important factor in scGFP uptake. These results also provide additional
mechanistic distinctions of scGFP uptake compared with the uptake of unstructured cationic
peptides, which have no significant effect on ERK1/2 phosphorylation (Figure 3F).
Disruption of endosomal transport and maturation by scGFPs and poly-Lys/Arg peptides
The amount of material per endosome, the rate of intracellular transport and maturation, and
the ultimate destination of endocytosed material are all parameters known to vary among
endocytic routes (Collinet et al., 2010). These distinctions can impact the characteristics and
effectiveness of protein delivery. A comparison of scGFP uptake, scGFP-mCherry uptake,
and functional Cre delivery (Figures 1B, 1C, and 1D) suggests charge-dependent differences
following internalization that contribute to the effectiveness of extraendosomal functional
delivery of protein cargoes. The high charge of cationic delivery reagents could alter the
ionic composition of the endosomal lumen. As the trafficking of endosomes is closely tied to
the function of endosomal membrane ion channels and pumps (Huotari and Helenius, 2011),
significant alteration through such a mechanism could disrupt endosome transport and
maturation. Endocytosed cargoes targeted for degradation are transported to perinuclear
lysosomal compartments within approximately 2 hours (Blanchette et al., 2009). The
effective cytosolic delivery of endocytosed material requires that it avoids degradation in the
endocytic pathway. A difference in the transport to lysosomes between scGFPs and cationic
peptides may explain the observed variations in protein delivery data described above.
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We monitored the transport of proteins to lysosomes following internalization by incubation
of HeLa cells with 500 nM of a protein of interest for 1 hour. Following this incubation,
cells were washed extensively with PBS containing heparin, and incubated a further 4 hours
in protein-free media containing heparin to prevent the uptake of any remaining extracellular
protein and inhibit the reinternalization of material from recycling endosomes. Dextran, a
marker of fluid-phase endocytosis (Oliver et al., 1984), was included as a control.
Lysosomes were labeled with the LysoTracker reagent (Life Technologies), which
effectively labels acidified lysosomes.
We performed co-localization analysis of Lysotracker dye with the scGFPs and cationic
peptide-tagged mCherry proteins to determine the extent of endosomal trafficking or
maturation disruption (Figure 4A). Dextran efficiently co-localized with lysosomes,
resulting in a Pearson's correlation coefficient (ρ) of 0.8. In contrast, all delivered proteins
displayed some level of significantly slower transport, with none exhibiting ρ > 0.6. In all
cases, large numbers of protein-containing peripheral endosomes were observed, even 4
hours after removal of the protein reagent from the media. Such a failure to localize to
perinuclear acidic vesicles suggests either a slowing of the maturation of protein-containing
endosomes or the sorting of scGFPs away from the degradative pathway. The observation of
a peripheral vesicles was not due to continued or recent internalization of proteins since the
cells were incubated in protein-free media following washing and prior to imaging.
Likewise, the apparent peripheral distribution was not due to the degradation and
disappearance of otherwise perinuclear lysosomal material over time, as the total cellular
fluorescence did not significantly decrease over the course of the 4-hour incubation
following treatment (Supplemental Information Figure S6).
The extent of lysosomal colocalization was significantly lower for all scGFPs compared
with any cationic peptide tested (Figure 4A). The scGFPs exhibited the least lysosomal co-
localization with a trend of decreased lyosomal localization with increased charge (Figure
4A). Within the CPP set of Tat, Arg10, and penetratin, the trend of colocalization strongly
reflected functional delivery properties, with Tat (the most potent delivery agent of the
cationic peptides in this study) exhibiting the lowest lysosomal colocalization. The
colocalization data for the poly-Lys/Arg peptides, in contrast, did not follow this trend.
While all poly-Lys/Arg peptides showed significantly reduced lysosomal co-localization
compared to dextran, they were among the poorest performing domains in the Cre
recombinase delivery assays (Figure 2C). Importantly, the localization of scGFP signal
strongly correlates with that of fused proteins of interest, such as Cre, even when the
proteins are cleaved (Figure S13).
Collectively, these lysosomal localization results reveal that the relative delivery abilities of
scGFPs and CPPs correlate with the extent of slowed endosomal maturation, and that scGFP
exhibits a stronger effect on these processes than CPPs. That such an effect correlates with
the potency of functional delivery suggests that the ultimate non-endosomal fate of delivered
proteins relies at least in part on how they are trafficked after internalization.
Kinetics of scGFP and cationic peptide uptake and trafficking
After observing the strong effect on endosome transport to lysosomes among the cationic
delivery reagents tested, we characterized the events of early endocytosis and tracked
differences between scGFPs and CPPs leading up to the observed late-stage endosomal
distribution using a recently reported high-throughput confocal microscopy image analysis
pipeline (Collinet et al., 2010). This platform enables the measurement of a wide range of
endosomal parameters, including trafficking kinetics, endosome number, size distribution,
and content. As representative proteins, we applied this strategy to the study of +36 GFP (a
high-potency supercharged protein), +15 GFP (a modestly potent supercharged protein),
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Tat-mCherry, penetratin-mCherry, and +30 (KKR)9KRR-mCherry (three cationic peptides
of varying charge and size) (for representative images see Figure S14).
HeLa cells were incubated with 0.1 to 2 μM of each protein for 30 minutes, washed, and
fixed (Figure S15). Over a range of concentrations, the number of scGFP or CPP-containing
vesicles increased steadily (Figure 5A). Among the proteins tested, +36 GFP occupied the
highest number of endosomes, even at low concentration (0.1 μM), while other proteins did
not occupy such a high number of endosomes even at the highest dose (2 μM). The +30
poly-Lys/Arg peptide exhibited a decrease in the number of endosomes formed at high
doses. Tat was only detected in a small number of endosomes, consistent with its modest
cell-uptake potency.
Importantly, over a range of protein concentrations, the amount of protein per endosome did
not exhibit a significant dose-dependent increase (Figure 5B). Endosomes with +36 GFP
contained roughly 4- to 10-fold more protein per endosome than endosomes with CPPs,
while +15 GFP-containing endosomes had roughly 2-fold more protein than CPPs. These
findings have important implications for interpreting the concentration dependence of
functional protein delivery. While the amount of protein per endosome is likely a factor
contributing to the overall effectiveness of protein functional delivery, as evidenced by the
relative amounts of protein per endosome for +36 GFP and +15 GFP versus CPPs (Figure
5B), the number of endosomes containing endocytosed protein, rather than the amount of
protein per endosome, more closely correlates with dose-dependent changes in functional
delivery potency. Increasing the dose of protein during treatments resulted in both more
protein-containing endosomes and more potent functional delivery (Figures 5A and 1D,
respectively).
We next measured the uptake and trafficking of proteins over time. Cells were incubated
with 500 nM proteins for up to 2 hours. +36 GFP rapidly entered cells, filling a maximal
number of early endosomes (identified by the presence of EEA1 (Rink et al., 2005)) within
10 minutes of treatment (Figure 4C). The other proteins were much slower in their uptake,
requiring as much as 2 hours before reaching maximal early endosome occupancy.
Thereafter, +36 GFP quickly exited early endosomal compartments. The rapid uptake and
transport to early endosomes of +36 GFP in comparison with the other proteins may reflect
the ability of this protein to be mainly internalized by clathrin-mediated endocytosis, as
described above (Figure 3A).
Over the course of two hours, a small fraction (< 20%) of +36 GFP eventually localized to
late endosomes compartments (identified by the presence of LAMP1) (Figure 4C).
Interestingly, the vast majority of +36 GFP protein is unaccounted for in either of these
major endosomal populations, and the number and size of both populations does not change
significantly over time (Figures S16A and B). The other proteins tested were slow to enter
both early endosomal compartments and late endosomal compartments, while a major
portion of the protein was retained outside of either of these endosomal populations, as with
+36 GFP. The amount of protein degradation post-endocytosis, as measured by loss of
fluorescence, was not appreciable for any of the proteins within the 2 hours tested. The lack
of degradation over this period, and even over a longer 16-hour incubation (Supplemental
Information Figure S12), suggests a role for dramatically slower lysosomal degradation in
functional protein delivery. Indeed, 80% of the original +36 GFP signal remained within
cells after 16 hours, indicating very little proteolysis of the endocytosed cargo. In contrast,
the intracellular lifetime of other endosomal cargo is comparatively short. For example,
transferrin can be recycled out of the cell rapidly, with an intracellular half-life of 7 minutes
(Ghosh et al., 1994); EGF is almost completely degraded within 2 hours (Carpenter and
Cohen, 1976); and polystyrene beads are transported to lysosomes within 2 hours
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(Blanchette et al., 2009). The presence of intact protein within an endosomal reservoir for
several hours post-internalization may provide a much greater opportunity for these proteins
to escape endosomes, even through a low-efficiency mechanism, than endosomal cargoes
that are rapidly degraded through canonical pathways.
Finally, we measured the amount of protein per endosome and the size of endosomes over
time. These two parameters are indicative of endosomal maturation and fusion, and may
determine the long-term fate of endocytosed proteins. Over 2 hours the average amount of
protein in each cell did not decrease for any protein tested. However, unique among all
proteins tested, the number of +36 GFP-containing endosomes decreased sharply (Figure
4C). Consequently, the amount of +36 GFP per endosome increased dramatically over time
(Figure 5C). This protein concentration effect was much less pronounced for the other
proteins tested, with +36 GFP reaching > 5-fold more protein per endosome than any other
agent tested, and achieving a 5-fold increase in the amount of protein per endosome over 2
hours. The other agents exhibited a much more modest increase in the amount of protein per
endosome during this time (Figure 5C). These measurements suggest that +36 GFP is not
significantly inhibiting homotypic fusion and cargo accumulation in endosomes. The size of
protein-containing endosomes did not change over time appreciably for any protein tested
(Figure 5D), and all endosomes were smaller compared to both early and late endosomes.
These observations suggest a role for the long-term intracellular survival of proteins within a
unique peripheral endosomal population during the process of functional protein delivery by
supercharged proteins and cationic peptides. The endosomes occupied by +36 GFP are
indeed acidified (Figure S17), yet they are not effectively transported to late endosomes
(Figure 4C) or lysosomes (Figure 4A). Our observations for +36 GFP may reflect a unique
trafficking alteration that is shared at least in part by other polycationic delivery reagents.
The specific cause and consequence of these changes is not obvious, but it is possible that a
high concentration of cationic moieties within an endosome disrupts lumenal ion
composition, preventing the maturation of protein-containing endosomes and their
subsequent fusion with degradative compartments. If the intra-endosomal survival of
proteins is extended as a result, then the delivery of functional extra-endosomal proteins
may strongly depend on such alterations to endosomal trafficking.
Discussion
In this study we found that the cellular uptake ability of supercharged GFPs exhibits a strong
sigmoidal charge dependence. Such a relationship suggests distinct interactions with cellular
components or uptake through different endocytic routes by high-charge, high-potency
scGFPs compared with CPPs or low-potency scGFPs. Indeed, our subsequent mechanistic
studies revealed that high-potency scGFPs alone require clathrin and dynamin for efficient
uptake, and modify the transport of clathrin-dependent endocytic cargoes. The potency of
scGFPs correlates with the level of activation of Rho and ERK1/2. Such activation may
involve the crosslinking of sulfated proteoglycans or other receptors on the cell surface, a
process known to induce macropinocytosis by CPPs (Imamura et al., 2011). If receptor
crosslinking is indeed the basis of endocytic activation by supercharged proteins, then
perhaps the extended surface area provided by highly charged variants explains their greater
observed potency compared with more modestly charged scGFPs or unstructured, short
cationic CPPs.
The endocytosis inhibitor and transferrin uptake studies described above suggest that scGFP
cellular uptake relies significantly on the induction of clathrin-dependent uptake. While
internalization of scGFPs is still dependent on the presence of anionic sulfated
proteoglycans, the studies above suggest that the major route of scGFP uptake is not
Thompson et al. Page 12
Chem Biol. Author manuscript; available in PMC 2013 January 27.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
macropinocytosis. These results, combined with the mechanistic studies implicating Rho
and ERK1/2 activation, suggest that scGFP uptake likely proceeds through multiple
pathways and depends most heavily on a proteoglycan-requiring, clathrin-dependent
process.
We observed that both scGFPs and CPPs undergo an altered process of trafficking following
endocytosis. The delivery agents tested here are not effectively transported to degradative
lysosomal compartments. Moreover, the endocytosed proteins are localized within
abnormally small peripheral endosomes that are negative for the early endosome marker
EEA1. The magnitude of the changes to endosomal transport correlates with the ability of
each reagent to deliver cytosolic proteins. To our knowledge, such changes in transport have
not yet been reported for non-viral delivery vehicles, and have important implications for the
survival of delivered proteins within cells. If protein-containing endosomes fail to mature
and efficiently fuse with lysosomal compartments, then delivered proteins may be provided
with an extended temporal window during which they can escape into the cytoplasm. Such a
phenomenon could contribute to the effectiveness of all cationic delivery vehicles,
especially high-potency supercharged proteins, which altered endosome trafficking more
than the other proteins and peptides studied here. The exact mechanism by which scGFPs
and CPPs disrupt endosomal transport is not yet understood and represents an attractive
subject of future studies. Supercharged GFPs also caused significant changes to the transport
of the endocytic cargoes transferrin and EGF, raising the possibility that supercharged
proteins have multiple effects on specific molecular components of the endocytic system
that lead to changes in transferrin receptor and EGF receptor recycling and degradation.
Together, our findings reveal new insights into the mechanism of cellular uptake and
trafficking of supercharged proteins and CPPs, and more generally highlight the importance
of studying at the subcellular level the interaction of delivery agents with their target cells.
Such studies improve our understanding of how macromolecule delivery agents work, and
identify means by which to optimize their function. These studies also suggest ways in
which exposure to such delivery agents can alter cell physiology, an important consideration
as macromolecular medicines become increasingly pervasive human therapeutics.
Significance
Supercharged proteins (Cronican et al., 2011; Cronican et al., 2010; McNaughton et al.,
2009) and other cell-penetrating agents based on folded protein domains (Smith et al., 2008;
Daniels and Schepartz, 2007; Fuchs and Raines, 2007) represent an emerging class of
macromolecule delivery agents that show improved potency in delivery applications
compared to unstructured cationic peptides. In the current study we discovered a highly
sigmoidal, ~100-fold charge-dependent increase in cell uptake for highly charged scGFPs
above that seen for other cationic delivery agents such as the Tat peptide (Figure 1A). This
charge-to-cell uptake relationship informs the future identification or engineering of proteins
for macromolecule delivery. The differences in endocytic transport (Figures 4A) by low-
and high-charge scGFPs and cationic peptides suggests that intracellular trafficking
processes also determine macromolecule delivery potency. Moreover, we have identified a
previously undescribed aspect of the interaction between macromolecule delivery agents and
their target cells. Using a detailed analysis of the subcellular endosomal transport of scGFPs
and cationic peptides, we found that all of these agents exhibit altered intracellular transport
across a number of parameters (Figures 4B, C and 5A–D), and none are as efficiently
transported to lysosomes as would be expected for typical endosomal cargo targeted for
degradation (Figure 4A). Given that lysosomal localization was anticorrelated with
functional delivery potency by these proteins, it seems likely that alteration of trafficking is
an important post-uptake factor in determining delivery potency, perhaps in part by
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extending their lifetime in cells. In summary, this study reveals protein and cellular factors
that determine the effectiveness of cationic protein- and peptide-based delivery agents, and
implicates specific pathways that may explain their significant potency differences.
Experimental Procedures
Complete experimental procedures are presented in the accompanying Supplemental
Information.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
• We generated a series of 28 “supercharged” green fluorescent proteins (GFPs)
of varying net charge and evaluated their cellular uptake and protein-delivery
capabilities.
• Supercharged proteins are endocytosed and deliver cytosolic protein in a
strongly charge-dependent manner, typically outperforming cationic peptides of
similar charge.
• Supercharged proteins stimulate endocytosis in a charge-dependent manner and
engage multiple endocytic pathways including clathrin-dependent endocytosis
and macropinocytosis.
• Endosomes containing supercharged proteins are not efficiently transported to
lysosomes.
• Supercharged proteins and cationic peptides alter endosomal transport in a
manner that correlates with their ability to deliver protein.
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Figure 1. Charge dependence of cellular uptake and protein delivery of supercharged GFPs
(A) and (B) HeLa cells were treated with 200 nM of each purified scGFP protein for 4
hours, washed to remove surface-bound protein and analyzed by flow cytometry. Plots show
fold median GFP fluorescence intensity relative to untreated control cells. Blue points
represent scGFPs generated by shuffling stGFP, +15 GFP, +25 GFP, and +36 GFP
sequences. Red points represent scGFPs generated by shuffling stGFP, +15 GFP, +25 GFP,
+36 GFP, and +48 GFP sequences to create proteins with less even charge density. Green
points represent starting +15, +25, +36, and +48 GFPs. The grey point is Tat-stGFP
(Cronican et al., 2010), and the black point is an arginine-grafted GFP (Fuchs and Raines,
2007). (C) HeLa cells were treated with the indicated scGFP-mCherry for 4 hours, washed,
and analyzed as in part (A). The plot shows median mCherry fluorescence of cells relative to
untreated cells. (D) BSR.LNL.tdTomato Cre reporter cells were treated with scGFP-Cre
fusions for 4 hours, washed, incubated an additional 48 hours, and assayed by flow
cytometry. (E) BSR.LNL.tdTomato reporter cells were treated and analyzed exactly as in
(D) except 100 mM chloroquine was added during the 4-hour protein incubation and for an
additional 12 hours after washing. Error bars represent the standard deviation of five ((A) to
(C)) or three ((D) and (E)) experiments. See also Figures S1, S2, S3, S4, S5, S11 and S12.
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Figure 2. scGFPs deliver mCherry and Cre recombinase more effectively than similarly charged
cationic peptides
Cells were treated and analyzed as described in Figure 1C. (A) Median mCherry
fluorescence of cells treated with scGFP-mCherry fusions or cationic peptide-mCherry
conjugates at the indicated doses for 4 hours. (B) mCherry delivery efficiency as a function
of protein net charge. (C) Percent recombinant BSR.LNL.tdTomato reporter cells expressing
tdTomato following treatment with scGFP-Cre fusions or cationic peptide-Cre conjugates.
Cells were treated and analyzed as described in Figure 1D. Error bars represent the standard
deviation of three experiments. See also Figures S1, S2, S3, S4, S5, S6, S7, S8, S11 and
S12.
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Figure 3. Effects of endocytic pathway probes on mCherry delivery by +36 GFP, effect of
supercharged proteins on the uptake of transferrin and EGF, and the activation of Rho-GTP
and ERK1/2 phosphorylation by scGFPs and cationic peptides
(A) Cells were pre-treated for 1 hour with the indicated inhibitor prior to 1-hour treatment
with 500 nM +36 GFP in the continued presence of inhibitor, washed, and analyzed by flow
cytometry. A mutant cell line, CHO pgsA−, which lacks heparin sulfate proteoglycans, and
treatment at 4 °C instead of 37 °C, were included as controls (grey bars). (B) and (C) HeLa
cells co-treated with the indicated cationic protein or peptide for 4 hours and Texas Red-
labeled transferrin (B), or Alexa 594-labeled EGF (C), were washed and analyzed by flow
cytometry. Transferrin and EGF uptake were normalized to cells treated with (B) Texas
Red-labeled transferrin or (C) Alexa 594-labeled EGF alone. (D), (E), and (F) CHO cells
(light bars) or CHO pgsA− cells (dark bars) were treated with 1 mM of the indicated scGFP
or cationic peptide for 5 minutes prior to washing and harvesting of cell lysate. EGF
treatment at 50 ng/mL was included as a control for endocytosis activation (“EGF”). (D)
Rho-GTP quantitation by GLISA. (E) Rac-GTP quantitation by GLISA. (F) The extent of
ERK1/2 phosphorylation determined by immunoblot with anti-phospho ERK1/2 antibody
and quantitated by densitometry. Error bars represent the standard deviation of three ((A)
and (C)) or five ((D) to (F)) experiments. See also Figures S1, S2, S9, S10, S11 and S12.
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Figure 4. Uptake and trafficking kinetics and lysosomal localization of scGFPs and cationic
peptides
(A) HeLa cells were treated with 500 nM of scGFP proteins or peptide-mCherry fusions for
1 hour, washed, incubated an additional 4 hours and imaged by confocal microscopy.
Lysosomes were labeled with LysoTracker Red or Green as appropriate (Life
Technologies). The colocalization of proteins with lysosomes was determined by calculation
of the Pearson's correlation coefficient of the red and green channels using ImageJ (left). A
representative image of cells treated with either FITC-dextran (top right) or +36 GFP
(bottom right) is shown. (B) and (C) HeLa cells were incubated with the indicated scGFP or
peptide-mCherry fusion at 500 nM for up to 2 hours and analyzed by confocal microscopy.
(B) The total amount of protein endocytosed over time. (C) Trafficking of protein through
early endosomes (labeled with anti-EEA1 antibody.(Rink et al., 2005)) and lysosomes
(labeled with anti-LAMP1 antibody (BD Pharmingen)). The number of GFP- or mCherry-
containing vesicles showing EEA1 or LAMP1 colocalization was an analyzed by high-
throughput automated confocal microscopy.(Collinet et al., 2010) In all plots, green points
represent the total number of vesicles containing scGFP or peptide-mCherry fusions; blue
points are vesicles showing EEA1 colocalization; and red points are vesicles showing
LAMP1 colocalization. All error bars represent the standard deviation of three experiments,
except in (A), which shows the standard deviation from 15 images. See also Figures S1, S2,
S11, S12, S13, S14, S16 and S17.
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Figure 5. Effects of scGFPs and cationic peptides on endosome formation, endosomal protein
content, and endosome surface area
(A) and (B) HeLa cells were incubated with the indicated concentrations of scGFP or
peptide-mCherry fusion for 1 hour, washed, and the number of GFP or mCherry-containing
endosomes was analyzed as in Figure 4B and C. (A) Supercharged proteins and cationic
peptides are endocytosed with greatly different potencies. (B) High-potency scGFPs result
fill endosomes with more protein than less potent scGFPs and cationic peptides. (C) and (D)
HeLa cells were treated and analyzed exactly as in Figure 4 and 4C. (C) Amount of GFP or
mCherry protein per endosome as a function of time. (D) Size of endosomes as a function of
time, with the average size of early endosomes and lysosomes indicated by the dotted and
solid lines, respectively. All error bars represent the standard deviation of three experiments.
See also Figures S1, S2, S9, S11, S12, S14, S15, S16 and S17.
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